BSE Live
Feb 10, 16:01Prev. Close
1545.60
Open Price
1535.20
Bid Price (Qty.)
1512.75 (19)
Offer Price (Qty.)
1512.75 (22)
NSE Live
Feb 10, 15:59Prev. Close
1545.70
Open Price
1546.00
Bid Price (Qty.)
1510.30 (102)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Emcure Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 427.71 | 199.91 | 212.34 | 616.42 | 557.45 | |
| Net CashFlow From Operating Activities | 558.29 | 584.97 | 505.37 | 427.71 | 774.87 | |
| Net Cash Used In Investing Activities | -435.61 | -171.08 | -270.44 | -189.00 | -831.16 | |
| Net Cash Used From Financing Activities | -49.25 | -287.75 | -54.52 | -342.96 | 30.97 | |
| Foreign Exchange Gains / Losses | -2.05 | -2.00 | -0.13 | -204.81 | -4.62 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 71.38 | 124.15 | 180.30 | -309.06 | -29.94 | |
| Cash And Cash Equivalents Begin of Year | -88.91 | -213.05 | -393.35 | -84.29 | -54.35 | |
| Cash And Cash Equivalents End Of Year | -17.53 | -88.91 | -213.05 | -393.35 | -84.29 |
10.02.2026
Emcure Pharmace Consolidated December 2025 Net Sales at Rs 2,363.48 crore, up 20.42% Y-o-Y
09.02.2026
Emcure Pharmace Standalone December 2025 Net Sales at Rs 1,418.31 crore, up 37.86% Y-o-Y
09.02.2026
09.01.2026
10.02.2026
Emcure Pharmace Consolidated December 2025 Net Sales at Rs 2,363.48 crore, up 20.42% Y-o-Y
09.02.2026
Emcure Pharmace Standalone December 2025 Net Sales at Rs 1,418.31 crore, up 37.86% Y-o-Y
17.11.2025
Emcure Pharmace Consolidated September 2025 Net Sales at Rs 2,269.82 crore, up 13.38% Y-o-Y
12.11.2025
Emcure Pharmace Standalone September 2025 Net Sales at Rs 1,260.60 crore, up 14.12% Y-o-Y